Creutzfeldt-Jakob disease and vision

Clinical and Experimental Optometry

Volumn 89, Issue 1, 2006, Pages 3-9

  Armstrong, Richard A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Corneal dendritic cells; Creutzfeldt Jakob disease (CJD); Prion hypothesis; Transmissible spongiform encephalopathy (tse); Visual signs and symptoms

Indexed keywords

ANIMAL; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; VISION; VISUAL DISORDER;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; RISK FACTORS; VISION DISORDERS; VISUAL PERCEPTION;

EID: 33645454472     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2006.00001.x     Document Type: Review

References (40)

1. Prusiner SB. The prion diseases. Scientific American 1995; 31-37.
2. Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with disease of the central nervous system. Cornea 1995;14:533-547.
3. Lueck C. Ocular features of CJD. Optician 2000;220:23-27.
4. Lueck CJ, McIlwaine GG, Zeidler M. Creutzfeldt-Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features. Eye 2000;14:291-301. (Pubitemid 30479700)
5. Amin SZ, Smith L, Luthert PJ, Cheetham ME, Buckley RJ. Minimising the risk of prion transmission by contact tonometry. Br J Ophthalmol 2003;87:1360-1362.
6. Douyi R, Kitamoyo T, Ogomori K, Mehraein P, Tateishi J. Distribution of prion protein in German patients with Creutzfeldt-Jakob disease is different from that of Japanese patients. Acta Neuropathol 1994;87:481-483.
7. DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion disease. Am J Pathol 1995;146:785-804.
8. Caughey B. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 2001;26:235-242. (Pubitemid 32289242)
9. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. The spatial pattern of the vacuolation ('spongiform change') in the cerebral cortex in variant Creutzfeldt-Jakob disease. Neurosci Res Communs 2002;30:43-50.
10. Prusiner SB, DeArmond SJ. Prion diseases and neurodegeneration. Annual Rev Neurosci 1994;17:311-339.
11. Armstrong RA, Cairns NJ, Lantos PL. The spatial pattern of the vacuolation in patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 2000;281:187-190.
12. Scott JR. Scrapie pathogenesis. Br Med Bull 1993;49:778-791.
13. Prince MJ, Bailey JA, Barrowman PR, Bishop KJ, Campbell GR, Wood JM. Bovine spongiform encephalopathy. Rev Sci Tech Off Inter Epiz 2003;22:37-60.
14. Collins S, McLean CA, Masters CL. Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia and kuru: a review of these less common human transmissible encephalopathies. J Clin Neurosci 2001;8:387-397.
15. Creutzfeldt HG. Über eines eigenartige herd-formige Erkrankung des Zentralner-vensystems. In: Nissl F, Alzheimer A, eds. Histologische und Histopathologische Arbeiten Über die Grosshirnrinde, Jena, Gustav Fisher; 1921. p 1-48.
16. Jakob A. über eigenartige Erkrankungen des Zentralnervensystems mit bemer-kenswerten anatomischen Befunden spastische Pseudosklerose-Encephalomy- elopathic mit disseminierten Degenera-tionsherden). Dtsch Z Nervenheilk 1921; 70:132-146.
17. Armstrong RA. Creutzfeldt-Jakob disease and vision. Optom Today 1997; April 4: 35-39.
18. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the United Kingdom. Lancet 1996;347:921-925.
19. Ironside JW. Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Supp 2000;16:143-151.
20. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. Quantification of vacuolations' ('Pongiform change'), surviving neurons and prion protein deposition in eleven cases of variant Creutzfeldt-Jakob disease. Neuro-pathol Appl Neurobiol 2002;28:129-135.
21. Kropp S, Schultz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S. The 'Heidenhain variant' of Creutzfeldt-Jakob disease. Arch Neurol 1999;56:55-61.
22. Vargas ME, Kupersmith MJ, Savino PJ, Petito F, Frohman LP, Warren FA. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol 1995;119:497-504.
23. Lesser RL, Albert DM, Bobowick AR. Creutzfeldt-Jakob disease and optic atrophy. Am J Ophthalmol 1979;87:317-321.
24. Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuro-Ophthalmol 1988;9:242-246.
25. Miller NR, Newman NJ. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Baltimore, Maryland: Williams and Wilkins, 1998.
26. Grant MP, Cohen M, Petersen RB, Halmagyi GM, McDougall A, Tusa RJ, Leigh RJ. Abnor-mal eye movements in Creutzfeldt-Jakob disease. Anns Neurol 1993;34:192-197.
27. Yokata T, Tsuchiya K, Yamane M, Hayashi M, Tanabe H, Tsukagoshi H. Geotropic ocular deviation with skew and absence of saccades in Creutzfeldt-Jakob disease. J Neurology 1991;106:175-178.
28. de Seze J, Hache JC, Vermersch P, Arndt CF, Maurage CA, Pasquier F, Laplanche JL, Ruchoux MM, Leys D, Destee A, Petit H. Creutzfeldt-Jakob disease: Neurophysiologic visual impairments. Neurology 1998;51:962-967.
29. Tsutsui J, Kawashima S, Kajikawa I, Shirabe T, Terao A. Electrophysiological and pathological studies on Creutzfeldt-Jakob disease with retinal involvement. Doc Ophthalmol 1986;63:13-26.
30. Aguglia V, Gambarelli D, Farnarier G, Quattrone A. Different susceptibilities of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease. Electroenceph Clin Neurophysiol 1991; 78:413-423.
31. Satish-Chandra P, Sharma P, Chatterji, Shankar SK. Psychiatric manifestations of Creutzfeldt-Jakob disease: probable neuro-pathological correlates. Neurology India 1996;44:43-46.
32. Anderson S, Tullo A. CJD and optometry: What are the risks? Optometry Today 2001; Oct. 19: 22-25.
33. Heckmann JG, Lang CJG, Petruch F, Druschky A, Erb C, Brown P, Neundorfer B. Transmission of Creutzfeldt-Jakob disease via a corneal transplant.J Neurol Neurosurg Psychiatr 1997;63:388-390.
34. Brown P, Calthala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895-904.
35. Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998;160:128-139.
36. Gibbs CJ, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimp by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatr 1994; 57:757-758.
37. Brown P. The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades. Cell Mole Life Sci 2001;58:259-265.
38. Sosnova M, Bradl M, Forrester JV. CD34 (+) corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells 2005;23:507-515.
39. Davanipour Z, Ziogus A, Sobel E, Smoak C, Doram K, Liwnicz B. Ocular tonometry and transmissible spongiform encephalopathy in humans. Am J Epidemiol 1998; 147 (suppl) : S76.
40. Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbuslous M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-180.